Emodin: A Promising Natural Compound for Combating Fibrotic Diseases

Abstract

Fibrotic diseases place a substantial burden on health and the economy, with limited treatment options. Therefore, effective therapeutic strategies are urgently needed. Emodin, a natural compound with diverse biological activities, has been demonstrated in multiple studies over recent years to have potential therapeutic effects on fibrotic diseases. This review aims to provide a comprehensive overview of the existing research on emodin’s pharmacological effects and mechanisms in inhibiting fibrotic disease, with a focus on its therapeutic advantages and systemic mechanisms. Recent studies have shown that emodin plays a role in combating fibrotic diseases by suppressing the production of inflammatory cytokines, such as IL-1β, IL-6, and TNF-α; it alleviates inflammation by inhibiting the NF-κB signaling pathway and preventing the degradation of IκB. Emodin also suppresses the activation of the MAPK pathway, enhances the expression of antioxidant enzymes, and influences the metabolism of the extracellular matrix (ECM). Thus, emodin is highlighted for its potential as an antifibrotic agent, and future research directions are proposed to deepen our understanding and develop novel treatment strategies for fibrotic diseases.

Keywords

Emodin / Inflammation / Fibrosis / Network pharmacology / Traditional Chinese Medicine / Natural product

References

[1] Brixey AG, Oh AS, Alsamarraie A, et al.. Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification. Chest., 2024, 165(4): 908-923

[2] Torre A, Martínez-Sánchez FD, Narvaez-Chávez SM, et al.. Pirfenidone use in fibrotic diseases: What do we know so far?. Immun Inflamm Dis., 2024, 12(7 e1335

[3] Zhang M, Zhang S. T Cells in Fibrosis and Fibrotic Diseases. Front Immunol., 2020, 11: 1142

[4] Dutta A, Chakraborty S, Roy A, et al.. Tissue fibrosis in cardiorenal syndrome: crosstalk between heart and kidneys. Nephrol Dial Transplant., 2025, 40(7): 1273-1283

[5] Hao L, Li S, Li C, et al.. A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease. Drug Des Devel Ther., 2025, 19: 83-96

[6] Sohail A, Shams F, Nawaz A, et al.. Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl(4)-induced liver fibrosis. Chem Biol Interact., 2025, 407 111384

[7] Kouadri A, Cormenier J, Gemy K, et al.. Copper-Associated Oxidative Stress Contributes to Cellular Inflammatory Responses in Cystic Fibrosis. Biomedicines., 2021, 9(4329

[8] Ma Y, Wang J, Fan J, et al.. Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy. Molecules., 2024, 30(120

[9] Yang F, Zhang Y, Dong L, et al.. Cordyceps cicadae ameliorates inflammatory responses, oxidative stress, and fibrosis by targeting the PI3K/mTOR-mediated autophagy pathway in the renal of MRL/lpr mice. Immun Inflamm Dis., 2024, 12(1 e1168

[10] Drummond D, Roy C, Cornet M, et al.. Acute respiratory failure due to pulmonary exacerbation in children with cystic fibrosis admitted in a pediatric intensive care unit: outcomes and factors associated with mortality. Respir Res., 2024, 25(1190

[11] Sun W, Zhao B, He Z, et al.. PLAC8 attenuates pulmonary fibrosis and inhibits apoptosis of alveolar epithelial cells via facilitating autophagy. Commun Biol., 2025, 8(148

[12] Cogliati B, Yashaswini CN, Wang S, et al.. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol., 2023, 20(10647-661

[13] Yang X, Li Q, Liu W, et al.. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol., 2023, 20(6): 583-599

[14] Zhang L, Liu C, Yin L, et al.. Mangiferin relieves CCl₄-induced liver fibrosis in mice. Sci Rep., 2023, 13(1): 4172

[15] Androutsakos T, Nasiri-Ansari N, Bakasis AD, et al.. SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection. Int J Mol Sci., 2022, 23(63107

[16] Tacke F, Puengel T, Loomba R, et al.. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol., 2023, 79(2552-566

[17] Zeng J, Fan JG, Francque SM. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European Gastroenterol J., 2024, 12(2): 177-186

[18] Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol., 2020, 21(7): 363-383

[19] Bezerra FS, Lanzetti M, Nesi RT, et al.. Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries. Antioxidants (Basel)., 2023, 12(3): 548

[20] Hu C, Wu Z, Li L. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med., 2020, 24(140-49

[21] Xiong G, Chen H, Wan Q, et al.. Emodin promotes fibroblast apoptosis and prevents epidural fibrosis through PERK pathway in rats. J Orthop Surg Res., 2019, 14(1): 319

[22] Feng L, Lin Z, Tang Z, et al.. Emodin improves renal fibrosis in chronic kidney disease by regulating mitochondrial homeostasis through the mediation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α). Eur J Histochem., 2024, 68(23917

[23] Gao Z, Sui J, Fan R, et al.. Emodin Protects Against Acute Pancreatitis-Associated Lung Injury by Inhibiting NLPR3 Inflammasome Activation via Nrf2/HO-1 Signaling. Drug Des Devel Ther., 2020, 14: 1971-1982

[24] Cui Y, Chen LJ, Huang T, et al.. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin. Chin J Nat Med., 2020, 18(6425-435

[25] Qin B, Zeng Z, Xu J, et al.. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin. BMC Cancer., 2022, 22(1): 671

[26] Stompor-Gorący M. The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update. Int J Mol Sci., 2021, 22(179522

[27] Wu CC, Chen MS, Chen JY. The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy. Biomedicines., 2024, 12(3486

[28] Semwal RB, Semwal DK, Combrinck S, et al.. Emodin - A natural anthraquinone derivative with diverse pharmacological activities. Phytochemistry., 2021, 190 112854

[29] Okon E, Gaweł-Bęben K, Jarzab A, et al.. Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer. Int J Mol Sci., 2023, 24(2115789

[30] Hu Y, Yang L, Lai Y. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms. Biomed Pharmacother., 2023, 162 114585

[31] Mitra S, Anjum J, Muni M, et al.. Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action. Biomed Pharmacother., 2022, 149 112877

[32] Nguyen LTH, Ahn SH, Shin HM, et al. Anti-Psoriatic Effect of Rheum palmatum L. and Its Underlying Molecular Mechanisms. Int J Mol Sci. 2022;23(24):16000.

[33] Zhang P, Zhang D, Zhou W, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform. 2023;25(1):bbad518.

[34] Li X, Liu Z, Liao J, et al.. Network pharmacology approaches for research of Traditional Chinese Medicines. Chin J Nat Med., 2023, 21(5323-332

[35] Siregar KAAK, Syaifie PH, Jauhar MM, et al.. Revealing curcumin therapeutic targets on SRC, PPARG, MAPK8 and HSP90 as liver cirrhosis therapy based on comprehensive bioinformatic study. J Biomol Struct Dyn., 2025, 43(6): 3172-3189

[36] Chen J, Li LF, Hu XR, et al. Network Pharmacology-Based Strategy for Elucidating the Molecular Basis Forthe Pharmacologic Effects of Licorice (Glycyrrhiza spp.). Front Pharmacol. 2021;12:590477.

[37] Selvarajah B, Platé M, Chambers RC. Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies. Mol Aspects Med., 2023, 94 101227

[38] Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med., 2012, 18(7): 1028-1040

[39] Lowe MM, Naik HB, Clancy S, et al.. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy. JCI Insight., 2020, 5(19 e139932

[40] Conti P, Caraffa A, Mastrangelo F, et al.. Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37. Cell Prolif., 2018, 51(5 e12475

[41] Yang AT, Kim YO, Yan XZ, et al.. Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis. Cell Mol Gastroenterol Hepatol., 2023, 15(4): 841-867

[42] Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol., 2022, 18(9): 545-557

[43] Peng Y, Li L, Shang J, et al.. Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment. Theranostics., 2023, 13(11): 3897-3913

[44] Liu F, Lagares D, Choi KM, et al.. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol., 2015, 308(4): L344-L357

[45] Shook BA, Wasko RR, Rivera-Gonzalez GC, et al. Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science. 2018;362(6417):eaar2971.

[46] Zanotti S, Gibertini S, Mora M. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment. Cell Tissue Res., 2010, 339(2): 397-410

[47] Isshiki T, Naiel S, Vierhout M, et al.. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases. Pharmacol Ther., 2024, 253 108578

[48] Peng D, Fu M, Wang M, et al.. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer., 2022, 21(1): 104

[49] Liu M, López de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504–519.

[50] Chen X, Tan H, Xu J, et al.. Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling. Kidney Int., 2022, 102(3506-520

[51] Gong W, Luo C, Peng F, et al.. Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt/β-catenin/autophagy axis. Clin Sci (Lond)., 2021, 135(15): 1873-1895

[52] Goto A, Komura S, Kato K, et al.. C-X-C domain ligand 14-mediated stromal cell-macrophage interaction as a therapeutic target for hand dermal fibrosis. Commun Biol., 2023, 6(1): 1173

[53] Antar SA, Ashour NA, Marawan ME, et al.. Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. Int J Mol Sci., 2023, 24(44004

[54] Otoupalova E, Smith S, Cheng G, et al.. Oxidative Stress in Pulmonary Fibrosis. Compr Physiol., 2020, 10(2509-547

[55] Wu H, Xu T, Chen T, et al.. Oxidative stress mediated by the TLR4/NOX2 signalling axis is involved in polystyrene microplastic-induced uterine fibrosis in mice. Sci Total Environ., 2022, 838(Pt 2 155825

[56] Bisaccia P, Magarotto F, D'Agostino S, et al.. Extracellular Vesicles From Mesenchymal Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of Bronchopulmonary Dysplasia. Stem Cells Transl Med., 2024, 13(1): 43-59

[57] Hu Y, Huang Y, Zong L, et al.. Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges. Cell Death Discov., 2024, 10(1): 301

[58] Wang W, Li K, Bai D, et al.. Pterostilbene: a potential therapeutic agent for fibrotic diseases. Inflammopharmacology., 2024, 32(2975-989

[59] Salminen A. AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration. Biogerontology., 2024, 25(1): 83-106

[60] Li J, Liu J, Yue W, et al.. Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-β1 in alveolar epithelial cells. J Cell Mol Med., 2020, 24(18): 10501-10511

[61] Zheng Q, Li S, Li X, et al.. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. Chin Med., 2021, 16(1): 102

[62] He KX, Ning JZ, Li W, et al.. Emodin alleviates testicular ischemia-reperfusion injury through the inhibition of NLRP3-mediated pyroptosis. Tissue Cell., 2023, 82 102069

[63] Mahmoud IS, Hatmal MM, Abuarqoub D, et al.. 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS Omega., 2021, 6(3925299-25310

[64] Sherekar P, Suke SG, Dhok A, et al.. Nano-enabled delivery of diosgenin and emodin ameliorates respirable silica dust-induced pulmonary fibrosis silicosis in rats. Ecotoxicol Environ Saf., 2024, 279 116483

[65] Wan J, Xu H, Ju J, et al.. Inhibition of hERG by ESEE suppresses the progression of colorectal cancer. Transl Oncol., 2024, 50 102137

[66] Josa E, Barril G, Ruperto M. Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review. Nutrients., 2024, 16(24): 4321

[67] Luo M, Shang L, Xie J, et al.. Current status and trend of global research on the pharmacological effects of emodin family: bibliometric study and visual analysis. Naunyn Schmiedebergs Arch Pharmacol., 2025, 398(66165-6178

[68] Guo Y, Song J, Liu Y, et al.. Study on the Hepatotoxicity of Emodin and Its Application in the Treatment of Liver Fibrosis. Molecules., 2024, 29(21): 5122

[69] Wei B, Li H, Wang C, et al.. Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment. Heliyon., 2024, 10(14 e34592

[70] Li XJ, Shan QY, Wu X, et al.. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cell Mol Life Sci., 2024, 81(1480

[71] Liu F, Zhang J, Qian J, et al.. Emodin alleviates CCl₄-induced liver fibrosis by suppressing epithelial-mesenchymal transition and transforming growth factor-β1 in rats. Mol Med Rep., 2018, 18(33262-3270

[72] Yang Q, Luo Y, Ge P, et al.. Emodin Ameliorates Severe Acute Pancreatitis-Associated Acute Lung Injury in Rats by Modulating Exosome-Specific miRNA Expression Profiles. Int J Nanomedicine., 2023, 18: 6743-6761

[73] Sougiannis AT, Enos RT, VanderVeen BN, et al.. Safety of natural anthraquinone emodin: an assessment in mice. BMC Pharmacol Toxicol., 2021, 22(1): 9

[74] Yang T, Wang J, Pang Y, et al.. Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact. Mol Med Rep., 2016, 14(54643-4649

[75] Gong L, Li Z, Xu M, et al.. Rational High-Throughput System for Screening Emodin High-Yielding Mutant from Marine Strains of Aspergillus flavipes HN4-13. Mar Drugs., 2025, 23(4): 174

[76] Ye Y, Zhong W, Luo R, et al.. Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis. J Nanobiotechnology., 2024, 22(133

[77] Hu B, Zhang H, Meng X, et al. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol. 2014;153(3):846–853.

[78] Liu B, Cheng Y, Wu Y, et al.. Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation. Int Immunopharmacol., 2020, 88 107020

[79] Shrimali D, Shanmugam MK, Kumar AP, et al.. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett., 2013, 341(2139-149

[80] Liu L, Zhang Y, Tang XR, et al.. Effect of emodin on acute lung injury: a meta-analysis of preclinical trials. BMC Pulm Med., 2024, 24(1): 596

[81] Xia X, He X, Huang J, et al.. Emodin induced hepatic steatosis in BALb/c mice by modulating the gut microbiota composition and fatty acid metabolism. Front Pharmacol., 2024, 15: 1516272

[82] Liu FJ, Gu TJ, Wei DY. Emodin alleviates sepsis-mediated lung injury via inhibition and reduction of NF-kB and HMGB1 pathways mediated by SIRT1. Kaohsiung J Med Sci., 2022, 38(3253-260

[83] Zheng Q, Wang J, Li W, et al.. Emodin Reverses the Epithelial-Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway. Drug Des Devel Ther., 2020, 14: 3663-3672

[84] Park SY, Choi YW, Park G. Nrf2-mediated neuroprotection against oxygen-glucose deprivation/reperfusion injury by emodin via AMPK-dependent inhibition of GSK-3β. J Pharm Pharmacol., 2018, 70(4525-535

[85] Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: A comprehensive review. Cell Biol Int., 2022, 46(6): 863-877

[86] Xue W, Yang L, Chen C, et al.. Wnt/β-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci., 2024, 81(1): 79

[87] Wang J, Yu H, Dong W, et al.. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways. Gastroenterology., 2023, 164(6990-1005

[88] Dong Y, Kang H, Peng R, et al.. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell Metab., 2024, 36(8): 1679-1695.e6

[89] Adinolfi S, Patinen T, Jawahar Deen A, et al.. The KEAP1-NRF2 pathway: Targets for therapy and role in cancer. Redox Biol., 2023, 63 102726

[90] Naguib S, Backstrom JR, Artis E, et al.. NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells. Acta Neuropathol Commun., 2023, 11(1): 171

[91] Shen G, Wen H, Li H, et al.. Emodin protects against severe acute pancreatitis-associated acute lung injury by activating Nrf2/HO-1/GPX4 signal and inhibiting ferroptosis in vivo and in vitro. BMC Gastroenterol., 2025, 25(157

[92] Fu C, Wu Y, Liu S, et al.. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol., 2022, 289 115021

[93] Huang W, Zhou P, Zou X, et al.. Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS/PI3K/Akt/mTOR axis. Clin Exp Hypertens., 2024, 46(12326022

[94] Chen C, Chen J, Wang Y, et al.. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Phytomedicine., 2023, 110 154626

[95] Geng K, Ma X, Jiang Z, et al.. WDR74 facilitates TGF-β/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice. Cell Biol Toxicol., 2023, 39(41577-1591

[96] Song P, Jo HS, Shim WS, et al.. Emodin induces collagen type I synthesis in Hs27 human dermal fibroblasts. Exp Ther Med., 2021, 21(5): 420

[97] Zhou L, Gao R, Hong H, et al.. Emodin inhibiting neutrophil elastase-induced epithelial-mesenchymal transition through Notch1 signalling in alveolar epithelial cells. J Cell Mol Med., 2020, 24(2011998-12007

[98] Ma T, Ma Y, Yu Y, et al.. Emodin Attenuates the ECM Degradation and Oxidative Stress of Chondrocytes through the Nrf2/NQO1/HO-1 Pathway to Ameliorate Rat Osteoarthritis. Oxid Med Cell Longev., 2022, 2022(1): 5581346

[99] Biel C, Faber KN, Bank RA, et al.. Matrix metalloproteinases in intestinal fibrosis. J Crohns Colitis., 2024, 18(3462-478

[100] Hu H, Song X, Li Y, et al.. Emodin protects knee joint cartilage in rats through anti-matrix degradation pathway: An in vitro and in vivo study. Life Sci., 2021, 269 119001

[101] Luo LP, Suo P, Ren LL, et al.. Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways. Front Pharmacol., 2021, 12 800522

[102] Chen L, Liang B, Xia S, et al.. Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation of glutaminase 1. Br J Pharmacol., 2023, 180(19): 2577-2598

[103] Zhao XA, Chen G, Liu Y, et al.. Curcumin reduces Ly6C(hi) monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomed Pharmacother., 2018, 106: 868-878

[104] Carver W, Fix E, Fix C, et al.. Effects of emodin, a plant-derived anthraquinone, on TGF-β1-induced cardiac fibroblast activation and function. J Cell Physiol., 2021, 236(11): 7440-7449

[105] Xiao D, Zhang Y, Wang R, et al.. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharm Sin B., 2019, 9(4): 724-733

[106] Lin Z, Zheng LC, Zhang HJ, et al.. Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells. BMC Complement Altern Med., 2015, 15: 259

[107] Guan R, Wang X, Zhao X, et al.. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Sci Rep., 2016, 6: 35696

[108] Tian SL, Yang Y, Liu XL, et al.. Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats. Med Sci Monit., 2018, 24: 1-10

[109] Jiang X, Yu M, Wang WK, et al.. The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin., 2024, 45(11): 2229-2240

[110] Xu L, Tan B, Huang D, et al.. Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys. Front Pharmacol., 2021, 12 626510

[111] Huang Z, Zhang Z, Zhou C, et al.. Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm., 2022, 3(2 e144

[112] Zhao W, Wang L, Yang J, et al.. Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration. Cell Commun Signal., 2023, 21(1): 56

[113] Liu W, Gu R, Lou Y, et al.. Emodin-induced autophagic cell death hinders epithelial-mesenchymal transition via regulation of BMP-7/TGF-β1 in renal fibrosis. J Pharmacol Sci., 2021, 146(4216-225

[114] Ding C, Wang Z, Dou X, et al.. Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis. Aging Dis., 2024, 15(4): 1508-1536

[115] Zheng XY, Yang SM, Zhang R, et al.. Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes. Drug Des Devel Ther., 2019, 13: 3171-3180

[116] Ivanovna LA, Akhiyarovna ML, Viktorovich PA, et al.. Morphological changes in fibrous tissue of rat myocardium after administration of dispersed allogeneic biomaterial. Vet Res Forum., 2025, 16(7): 381-386

[117] López B, Ravassa S, Moreno MU, et al.. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol., 2021, 18(7): 479-498

[118] Chen KJ, Zhang Y, Zhu XY, et al.. GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis. Mil Med Res., 2025, 12(1): 26

[119] Gu X, Zhang Z, Zhao L, et al.. Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome. J Hazard Mater., 2025, 488 137410

[120] Tani H, Sadahiro T, Yamada Y, et al.. Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction. Circulation., 2023, 147(3223-238

[121] Weng L, Ye J, Yang F, et al.. TGF-β1/SMAD3 Regulates Programmed Cell Death 5 That Suppresses Cardiac Fibrosis Post-Myocardial Infarction by Inhibiting HDAC3. Circ Res., 2023, 133(3): 237-251

[122] Zhang Q, Wang L, Wang S, et al.. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther., 2022, 7(1): 78

[123] Yu J, Zhao X, Yan X, et al.. Aloe-emodin ameliorated MI-induced cardiac remodeling in mice via inhibiting TGF-β/SMAD signaling via up-regulating SMAD7. Phytomedicine., 2023, 114 154793

[124] Wang WB, Li JT, Hui Y, et al.. Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway. Chin Med., 2022, 17(119

[125] Zhang Z, Luo Y, Zhuang X, et al.. Emodin alleviates lung injury via the miR-217-5p/Sirt1 axis in rats with severe acute pancreatitis. J Pharmacol Sci., 2024, 156(3188-197

[126] Song B, Zeng Y, Cao Y, et al.. Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications. Front Immunol., 2023, 14: 1221609

[127] Andugulapati SB, Gourishetti K, Tirunavalli SK, et al.. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine., 2020, 78 153298

[128] Politis PK, Charonis AS. Calreticulin in renal fibrosis: A short review. J Cell Mol Med., 2022, 26(24): 5949-5954

[129] Xu C, Pascual-Sabater S, Fillat C, et al.. The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. Biochem Pharmacol., 2024, 228 116509

[130] Yang F, Deng L, Li J, et al.. Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ-Smad Signaling Pathway. Drug Des Devel Ther., 2020, 14: 3567-3575

[131] Song L, Zhang W, Tang SY, et al.. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. Biomed Pharmacother., 2024, 170 116039

[132] Wang R, Wan Q, Zhang Y, et al.. Emodin suppresses interleukin-1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life Sci., 2007, 80(262481-2488

[133] Jeerangsapasuk W, Charoenpitakchai M, Sornwiboonsak P, et al.. A Challenging Case of IgG4-Related Kidney Disease Accompanied With Positive Serologic Tests of Lupus Erythematosus. Nephrology (Carlton)., 2025, 30(1 e14429

[134] Nishimoto M, Griffin KA, Wynne BM, et al.. Salt-Sensitive Hypertension and the Kidney. Hypertension., 2024, 81(6): 1206-1217

[135] Wheeler DC, Toto RD, Stefánsson BV, et al.. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Kidney Int., 2021, 100(1): 215-224

[136] Voko MP, Ogbe AA, Kulkarni MG, et al.. The Phytochemical Composition and Molecular Mechanisms Involved in the Wound Healing Attributes of Bulbine Species-A Critical Review. Plants (Basel)., 2025, 14(19): 3045

[137] Wang L, Wang X, Li G, et al.. Emodin ameliorates renal injury and fibrosis via regulating the miR-490-3p/HMGA2 axis. Front Pharmacol., 2023, 14: 1042093

[138] Hou Y, Zhu L, Ye X, et al.. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation. J Nanobiotechnol., 2024, 22(1305

[139] Du X, Niu R, Liu X, et al.. Nanomedicines in the Treatment of Liver Fibrosis: A Review. Int J Nanomedicine., 2025, 20: 9641-9665

[140] Kim CG, Jang M, Oh C, et al.. Pulmonary surfactant-based pirfenidone-loaded nanovesicles for inhalation therapy of idiopathic pulmonary fibrosis. J Control Release., 2025, 385 114005

[141] Wu CC, Chen MS, Lee TY, et al.. Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions. Virol J., 2023, 20(1148

[142] Sun J, Sun A, Wang Y, et al.. Liposomal Emodin: A nanomedicine for two-photon imaging and mitochondria-targeted photodynamic therapy of psoriasis. Biomaterials., 2026, 325 123631

[143] Liu L, Zou J, Liu X, et al.. Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor. Eur J Pharmacol., 2010, 640(1–315-19

[144] Lin SP, Chu PM, Tsai SY, et al.. Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats. J Ethnopharmacol., 2012, 144(3): 671-676

[145] Shia CS, Hou YC, Tsai SY, et al.. Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats. J Pharm Sci., 2010, 99(4): 2185-2195

[146] Wu W, Yan R, Yao M, et al.. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract. Biomed Chromatogr., 2014, 28(4): 564-572

Funding

National Conference on Undergraduate Innovation and Entrepreneurship(202510226099)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to the Huazhong University of Science and Technology

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.